As well as working with our clients, Mycosynthetix has in-house discovery projects addressing cancer and neglected diseases; these are summarized in the table below together with our fungal product out-licensing opportunities 오라클 10g 클라이언트 64비트 다운로드. Please contact Dr. Cedric Pearce at cpearce@.mycosynthetix.com for additional details.
|Application||Target||Status January 2012|
The development of mevalocidin for organic farming relux pro 다운로드. The optimization is being funded through a Phase 1 SBIR award from the USDA-NIFA program.
|Herbicide||Novel herbicide identified and patented (by Dow AgroSciences LLC – see elsewhere on this site) now under development in our laboratories 사파리 동영상 다운로드.|
Collaboration with Professor N. Oberlies of the the University of North Carolina Greensboro and funded by a Program Grant from the National Cancer Institute (PO1-CA125066) through The Ohio State University (Professor Douglas Kinghorn) Download Bipo Midnight.
|Cytotoxicity, various cells||Novel active compounds identified and evaluated in the NCI 60 cell line panel. Provisional patents being filed mysql workbench 32bit. Other lead fungi being analyzed and evaluated.|
Collaboration with Professor Scott Franzblau of the Institute for Tuberculosis Research, University of Illinois – Chicago 안드로이드 마시멜로우 다운로드.
|Tuberculosis||Active fungi being evaluated and prioritized.|
Collaboration with Professors B 이까리 다운로드. Baker and D. Kyle of the University of South Florida to discover new malaria medicines.
Collaboration with Professor A.Satoskar, OSU to discover endophytic fungi which produce anti-leishmania compounds 프린세스메이커3 다운로드.
|Malaria, Leishmaniasis||Screening and evaluation of active fungi on-going. Leishmaniasis research funded through the NIH.|